Syngene International Limited

NSEI:SYNGENE Rapport sur les actions

Capitalisation boursière : ₹334.7b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Syngene International Gestion

Gestion contrôle des critères 2/4

Le PDG Syngene International's est Jonathan Hunt, nommé en Jan2016, a un mandat de 8.58 ans. La rémunération annuelle totale est ₹ 285.33M, composée du salaire de 50% et des bonus 50%, y compris les actions et options de la société. détient directement 0.062% des actions de la société, d'une valeur de ₹ 204.41M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 7.5 ans et 6 ans.

Informations clés

Jonathan Hunt

Directeur général

₹285.3m

Rémunération totale

Pourcentage du salaire du PDG50.0%
Durée du mandat du directeur général8.6yrs
Propriété du PDG0.06%
Durée moyenne d'occupation des postes de direction7.5yrs
Durée moyenne du mandat des membres du conseil d'administration6yrs

Mises à jour récentes de la gestion

Recent updates

Syngene International Limited's (NSE:SYNGENE) Popularity With Investors Is Under Threat From Overpricing

Jul 16
Syngene International Limited's (NSE:SYNGENE) Popularity With Investors Is Under Threat From Overpricing

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Mar 28
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?

Feb 14
Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?

Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)

Jan 19
Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)

Is Syngene International (NSE:SYNGENE) A Risky Investment?

Nov 19
Is Syngene International (NSE:SYNGENE) A Risky Investment?

Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?

Nov 01
Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?

Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly

Aug 07
Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Apr 28
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching

Apr 06
Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching

Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Jan 04
Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet

Dec 08
Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet

Is Syngene International (NSE:SYNGENE) Using Too Much Debt?

Aug 28
Is Syngene International (NSE:SYNGENE) Using Too Much Debt?

Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 10
Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well

May 10
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well

Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?

Feb 02
Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?

Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Nov 26
Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly

Sep 21
Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly

Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock

Aug 06
Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock

Analyse de la rémunération des PDG

Comment la rémunération de Jonathan Hunt a-t-elle évolué par rapport aux bénéfices de Syngene International?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

₹5b

Mar 31 2024₹285m₹143m

₹5b

Dec 31 2023n/an/a

₹5b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹5b

Mar 31 2023₹85m₹85m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹4b

Jun 30 2022n/an/a

₹4b

Mar 31 2022₹76m₹76m

₹4b

Dec 31 2021n/an/a

₹4b

Sep 30 2021n/an/a

₹4b

Jun 30 2021n/an/a

₹4b

Mar 31 2021₹65m₹65m

₹4b

Dec 31 2020n/an/a

₹4b

Sep 30 2020n/an/a

₹4b

Jun 30 2020n/an/a

₹4b

Mar 31 2020₹66m₹66m

₹4b

Dec 31 2019n/an/a

₹4b

Sep 30 2019n/an/a

₹4b

Jun 30 2019n/an/a

₹3b

Mar 31 2019₹90m₹47m

₹3b

Dec 31 2018n/an/a

₹3b

Sep 30 2018n/an/a

₹3b

Jun 30 2018n/an/a

₹3b

Mar 31 2018₹94m₹47m

₹3b

Rémunération vs marché: La rémunération totale de Jonathan ($USD 3.40M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 591.43K ).

Rémunération et revenus: La rémunération de Jonathan a augmenté de plus de 20 % au cours de l'année écoulée.


PDG

Jonathan Hunt (55 yo)

8.6yrs

Titularisation

₹285,330,000

Compensation

Mr. Jonathan Brittan Hunt serves as the Managing Director of Syngene International Limited since April 1, 2020. He has been the Chief Executive Officer of Syngene International Ltd. since January 2016 and...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Jonathan Hunt
MD, CEO & Executive Director8.6yrs₹285.33m0.062%
₹ 206.7m
Sibaji Biswas
CFO & Executive Director4.7yrs₹34.14m0.017%
₹ 56.8m
Krishnan G
Head of Investor Relationsno datapas de données0.0028%
₹ 9.4m
Priyadarshini Mahapatra
Head of Legal5.1yrs₹4.72m0.0024%
₹ 8.0m
Sandeep Nair
Head of Corporate Communicationsno datapas de donnéespas de données
Andrew Webster
Chief Human Resources Officer1.7yrspas de donnéespas de données
Dhananjay Patankar
Head of Pharmaceutical & Biopharmaceutical Developmentno data₹10.80mpas de données
Purushottam Singnurkar
Head of Formulations Developmentno data₹5.50m0.025%
₹ 83.3m
Ajit Manocha
Head of IT8.5yrspas de données0.0029%
₹ 9.7m
Jayashree Aiyar
Head of Discovery Biology8.6yrspas de données0%
₹ 0
Chetan Tamhankar
Head of Clinical Development & Stability Studies8.6yrspas de données0.0040%
₹ 13.5m
Rajendra Patil
Head of EHSS6.6yrspas de données0.0093%
₹ 31.3m

7.5yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de SYNGENE est chevronnée et expérimentée (ancienneté moyenne 7.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jonathan Hunt
MD, CEO & Executive Director7.3yrs₹285.33m0.062%
₹ 206.7m
Sibaji Biswas
CFO & Executive Directorless than a year₹34.14m0.017%
₹ 56.8m
Catherine Rosenberg
Non-Executive Director24yrs₹8.28m0.0022%
₹ 7.3m
Kiran Mazumdar-Shaw
Non-Executive Chairpersonno data₹9.43m0.0055%
₹ 18.3m
Vinita Bali
Lead Independent Director7.1yrs₹8.62mpas de données
Vijay Kuchroo
Independent Director7.4yrs₹7.46m0.012%
₹ 41.7m
Nilanjan Roy
Additional Independent Directorless than a yearpas de donnéespas de données
Kush Parmar
Independent Non Executive Director3.2yrs₹6.47mpas de données
Paul Blackburn
Non-Executive Independent Director10yrs₹9.12m0.012%
₹ 41.7m
Manja Boerman
Independent Directorless than a yearpas de donnéespas de données
Sharmila Karve
Additional Independent Director5yrs₹8.46mpas de données

6.0yrs

Durée moyenne de l'emploi

63yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de SYNGENE sont considérés comme expérimentés (ancienneté moyenne 6 ans).